Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A
- PMID: 9099848
- DOI: 10.1007/s004390050403
Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A
Abstract
Congenital MHC class II deficiency or bare lymphocyte syndrome (BLS; McKusick 209920) is caused by defects in trans-acting regulatory factors that control MHC class II expression and is therefore a disease of gene regulation. There are at least four complementation groups and the genetic and molecular dissection of this rare disease has contributed considerably to our current understanding of the molecular mechanisms governing MHC class II expression. Identification of the gene that is defective in BLS complementation group A, CIITA (MHC class II transactivator), has led to the discovery that CIITA acts as a master control factor of MHC class II expression. We have identified the CIITA mutations in a second patient from BLS group A. Two novel mutations abolish CIITA function, as shown by transfection experiments. Molecular analysis of these two novel mutations, together with the one described earlier in the first patient, is informative in terms of CIITA structure-function relationships.
Similar articles
-
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).Cell. 1993 Oct 8;75(1):135-46. Cell. 1993. PMID: 8402893
-
Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.J Immunol. 2000 Apr 1;164(7):3666-74. doi: 10.4049/jimmunol.164.7.3666. J Immunol. 2000. PMID: 10725724
-
Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene.Immunogenetics. 2000 Jan;51(1):42-9. doi: 10.1007/s002510050007. Immunogenetics. 2000. PMID: 10663561
-
Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.Immunol Rev. 2000 Dec;178:148-65. doi: 10.1034/j.1600-065x.2000.17813.x. Immunol Rev. 2000. PMID: 11213800 Review.
-
Molecular genetics of the Bare lymphocyte syndrome.Rev Immunogenet. 2000;2(2):267-82. Rev Immunogenet. 2000. PMID: 11258423 Review.
Cited by
-
CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.Genes Dev. 2000 May 1;14(9):1156-66. Genes Dev. 2000. PMID: 10809673 Free PMC article.
-
A Novel RFXANK Mutation in a Chinese Child With MHC II Deficiency: Case Report and Literature Review.Open Forum Infect Dis. 2020 Jul 24;7(8):ofaa314. doi: 10.1093/ofid/ofaa314. eCollection 2020 Aug. Open Forum Infect Dis. 2020. PMID: 32875002 Free PMC article.
-
NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.J Leukoc Biol. 2008 Jan;83(1):13-30. doi: 10.1189/jlb.0607402. Epub 2007 Sep 17. J Leukoc Biol. 2008. PMID: 17875812 Free PMC article. Review.
-
CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.Mol Cell Biol. 2000 Oct;20(20):7716-25. doi: 10.1128/MCB.20.20.7716-7725.2000. Mol Cell Biol. 2000. PMID: 11003667 Free PMC article.
-
The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.Am J Hum Genet. 1999 Aug;65(2):279-86. doi: 10.1086/302519. Am J Hum Genet. 1999. PMID: 10417269 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
